Hematopoietic and Lymphatic System Neoplasm

Hematopoietic and Lymphatic System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 371 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05874193	A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma(COSTA)	withdrawn	Phase 2	0	Cristiana Costa Chase, DOOTHER	1	Sep 28, 2026	clinicaltrials
NCT06597734	A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm	withdrawn	Phase 2	0	M.D. Anderson Cancer CenterOTHER